EDTUTC-4 New YorkLog in Sign up

LPCN
Lipocine Inc.
stockNASDAQ

At CloseOct 7, 2026 3:59:46 PM EDT

2.18USD+3.810%(+0.08)105,166,456

2.1900Bid2.5200Ask0.3300Spread

Pre-marketOct 7, 2026 9:29:57 AM EDT

2.96USD+40.952%(+0.86)

After-hoursOct 7, 2026 4:59:30 PM EDT

2.16USD-0.917%(-0.02)

Loading…

Loading…

18.14M

Healthcare

Biotechnology

CEO

Mahesh Patel

HQ

Salt Lake City, UT, USA

14

Previous Close

$2.10

Beta

1.40

52-Week High

$12.37 2026-01-15

52-Week Low

$1.81 2026-04-02

SMA 50

$2.16

SMA 200

$4.39

Avg. Vol 10D

38,903

Avg. Vol 30D

35,047

Avg. Vol 90D

54,172

Relative Vol

804.23

8.24M

7.87M

95.47%

99,444

Short Interest %

1.26%

4.58

On/Off Exchange

61%/39%

59.74%

Short Vol % (off-exch)

51.06%

0.4100%

80,000

999

1,021

1,034

Nov 5, 2026 (29d)

May 12, 2023 · 1-for-17 (reverse)

Oct 7, 2026

08:54 AM EDTLipocine stock surges 30% on Health Canada drug approval ·

Investing.com

08:00 AM EDTLipocine Announces Health Canada Approval of TLANDO® for Testosterone Replacement Therapy ·

PR Newswire

Oct 5, 2026

01:45 PM EDTMonday 10/5 Insider Buying Report: LPCN, CSWC ·

BNK Invest

Oct 1, 2026

09:45 PM EDTLipocine director John Higuchi buys $55,042 in company stock ·

Investing.com

Sep 30, 2026

09:01 PM EDTLipocine director John Higuchi buys $27,131 in company stock ·

Investing.com

LPCN Profile

lipocine inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products. the company develops drugs based on hydroance, a drug delivery technology. it primarily focuses on developing oral versions of several hormones for use in men and women health. the company's lipid-based technology platform offers non-invasive delivery solutions for small polar organics and macromolecules. it also offers custom drugs for pharmaceutical/biotechnology companies. lipocine inc. was founded in 1997 and is headquartered in salt lake city, utah.

LPCN Performance

Period	Price	Date	Change	Beta
1M	2.36	2026-09-08	-6.78%	1.482
3M	2.47	2026-07-07	-10.93%	1.297
6M	2.00	2026-04-07	+10.00%	1.561
1Y	3.22	2025-10-07	-31.68%	1.404
2Y	4.99	2024-10-07	-55.91%	—
5Y	17.68	2021-10-07	-87.56%	0.792

LPCN Stock Summary

Lipocine Inc. (NASDAQ:LPCN) stock price today is $2.20, and today's volume is 28,185,786. LPCN is up 4.762% today. The 30 day average volume is 35,047. LPCN market cap is $18.14M with 8.24M shares outstanding.